1921
Volume 86, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Home management of malaria is recommended for prompt, effective antimalarial treatment in children less than five years of age. Compliance, safety, and effectiveness of the new fixed-dose artesunate-amodiaquine regimen used to treat suspected malaria were assessed in febrile children enrolled in a 24-month cohort study in two settings in Madagascar. Children with fever were asked to visit community health workers. Presumptive antimalarial treatment was given and further visits were scheduled for follow-up. The primary endpoint was the risk of clinical/parasitologic treatment failure. Secondary outcomes included fever/parasite clearance, change in hemoglobin levels, and frequency of adverse events. The global clinical cure rate was 98.4% by day 28 and 97.9% by day 42. Reported compliance was 83.4%. No severe adverse effects were observed. This study provides comprehensive data concerning the clinical cure rate obtained with artesunate-amodiaquine and evidence supporting the scaling up of home management of malaria.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.2012.11-0047
2012-02-01
2020-08-15
Loading full text...

Full text loading...

/deliver/fulltext/14761645/86/2/203.html?itemId=/content/journals/10.4269/ajtmh.2012.11-0047&mimeType=html&fmt=ahah

References

  1. Snow RW, Guerra CA, Mutheu JJ, Hay SI, 2008. International funding for malaria control in relation to populations at risk of stable Plasmodium falciparum transmission. PLoS Med 5: e142.[Crossref]
    [Google Scholar]
  2. Foster S, 1995. Treatment of malaria outside the formal health services. J Trop Med Hyg 98: 2934.
    [Google Scholar]
  3. Kager PA, 2002. Malaria control: constraints and opportunities. Trop Med Int Health 7: 10421046.[Crossref]
    [Google Scholar]
  4. Moerman F, Lengeler C, Chimumbwa J, Talisuna A, Erhart A, Coosemans M, D'Alessandro U, 2003. The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis 3: 99102.[Crossref]
    [Google Scholar]
  5. Wiseman V, Scott A, Conteh L, McElroy B, Stevens W, 2008. Determinants of provider choice for malaria treatment: experiences from The Gambia. Soc Sci Med 67: 487496.[Crossref]
    [Google Scholar]
  6. World Health Organization, 2004. Scaling Up Home-Based Management of Malaria: from Research to Implementation. Geneva: World Health Organization.
    [Google Scholar]
  7. World Health Organization, 2005. The Roll Back Malaria Strategy for Improving Access to Treatment through Home Management of Malaria. Geneva: World Health Organization WHO/HTM/MAL/2005.1101.
    [Google Scholar]
  8. Greenwood B, Marsh K, Snow R, 1991. Why do some African children develop severe malaria? Parasitol Today 7: 277281.[Crossref]
    [Google Scholar]
  9. D'Alessandro U, Talisuna A, Boelaert M, 2005. Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? Trop Med Int Health 10: 12.[Crossref]
    [Google Scholar]
  10. Ratsimbasoa A, Randrianarivelojosia M, Millet P, Soares JL, Rabarijaona L, Rakotoson B, Malvy D, Menard D, 2006. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children. Malar J 5: 79.[Crossref]
    [Google Scholar]
  11. Andriantsoanirina V, Menard D, Tuseo L, Durand R, 2010. History and current status of Plasmodium falciparum antimalarial drug resistance in Madagascar. Scand J Infect Dis 42: 2232.[Crossref]
    [Google Scholar]
  12. Menard D, Ratsimbasoa A, Randrianarivelojosia M, Rabarijaona LP, Raharimalala L, Domarle O, Randrianasolo L, Randriamanantena A, Jahevitra M, Andriantsoanirina V, Rason MA, Raherinjafy R, Rakotomalala E, Tuseo L, Raveloson A, 2008. Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: up-dated baseline data from randomized and multi-site clinical trials. Malar J 7: 55.[Crossref]
    [Google Scholar]
  13. Pagnoni F, 2009. Malaria treatment: no place like home. Trends Parasitol 25: 115119.[Crossref]
    [Google Scholar]
  14. Menard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA, 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci USA 107: 59675971.[Crossref]
    [Google Scholar]
  15. Barnes KI, Durrheim DN, Little F, Jackson A, Mehta U, Allen E, Dlamini SS, Tsoka J, Bredenkamp B, Mthembu DJ, White NJ, Sharp BL, 2005. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PLoS Med 2: e330.[Crossref]
    [Google Scholar]
  16. Depoortere E, Guthmann JP, Sipilanyambe N, Nkandu E, Fermon F, Balkan S, Legros D, 2004. Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia. Trop Med Int Health 9: 6267.[Crossref]
    [Google Scholar]
  17. Depoortere E, Salvador ET, Stivanello E, Bisoffi Z, Guthmann JP, 2004. Adherence to a combination of artemether and lumefantrine (Coartem) in Kajo Keji, southern Sudan. Ann Trop Med Parasitol 98: 635637.[Crossref]
    [Google Scholar]
  18. World Health Organization, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated falciparum Malaria. Geneva: World Health Organization.
    [Google Scholar]
  19. World Health Organization, 1996. Management of Uncomplicated Malaria and the Use of Antimalarial Drugs for the Protection of Travellers: Report of an Informal Consultation (WHO/MAL/96). Geneva: World Health Organization.
    [Google Scholar]
  20. Mangold KA, Manson RU, Koay ES, Stephens L, Regner M, Thomson RB Jr, Peterson LR, Kaul KL, 2005. Real-time PCR for detection and identification of Plasmodium spp. J Clin Microbiol 43: 24352440.[Crossref]
    [Google Scholar]
  21. Rakotonirina H, Barnadas C, Raherijafy R, Andrianantenaina H, Ratsimbasoa A, Randrianasolo L, Jahevitra M, Andriantsoanirina V, Menard D, 2008. Accuracy and reliability of malaria diagnostic techniques for guiding febrile outpatient treatment in malaria-endemic countries. Am J Trop Med Hyg 78: 217221.
    [Google Scholar]
  22. Cattamanchi A, Kyabayinze D, Hubbard A, Rosenthal PJ, Dorsey G, 2003. Distinguishing recrudescence from reinfection in a longitudinal antimalarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. Am J Trop Med Hyg 68: 133139.
    [Google Scholar]
  23. Hopkins H, Talisuna A, Whitty CJ, Staedke SG, 2007. Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence. Malar J 6: 134.[Crossref]
    [Google Scholar]
  24. Ajayi IO, Browne EN, Bateganya F, Yar D, Happi C, Falade CO, Gbotosho GO, Yusuf B, Boateng S, Mugittu K, Cousens S, Nanyunja M, Pagnoni F, 2008. Effectiveness of artemisinin-based combination therapy used in the context of home management of malaria: a report from three study sites in sub-Saharan Africa. Malar J 7: 190.[Crossref]
    [Google Scholar]
  25. Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, Houze P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P, 2009. Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis 200: 5765.[Crossref]
    [Google Scholar]
  26. Ajayi IO, Browne EN, Garshong B, Bateganya F, Yusuf B, Agyei-Baffour P, Doamekpor L, Balyeku A, Munguti K, Cousens S, Pagnoni F, 2008. Feasibility and acceptability of artemisinin-based combination therapy for the home management of malaria in four African sites. Malar J 7: 6.[Crossref]
    [Google Scholar]
  27. White NJ, 2004. Antimalarial drug resistance. J Clin Invest 113: 10841092.[Crossref]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2012.11-0047
Loading
/content/journals/10.4269/ajtmh.2012.11-0047
Loading

Data & Media loading...

  • Received : 21 Jan 2011
  • Accepted : 24 Jun 2011
  • Published online : 01 Feb 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error